Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06348498
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-03-12
Brief Title:
Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure
Sponsor:
Tasly Pharmaceutical Group Co Ltd
Organization:
Tasly Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A Open Label Standardise-loaded and Single-Centre Phase Ⅰb Clinical TrialPharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate the pharmacokinetic and pharmacodynamic characteristics of Jia Shen Tablets in patients with Chronic Heart Failure
Detailed Description:
Jia Shen Tablets are oral compound traditional chinese medicine This open label standardise-loaded and single-Centre phase Ⅰb clinical trial will evaluate the pharmacokinetic and pharmacodynamic characteristics of Jia Shen Tablets in treatment of coronary heart disease complicating chronic heart failure syndrome of Yang deficiency with blood stasis and preliminarily evaluate the efficacy and safety
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None